Predicting plasma protein binding of drugs: a new approach (Q78408599)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392818 AND SRC:MED&resulttype=core&format=json

14 December 2019

title

Predicting plasma protein binding of drugs: a new approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392818 AND SRC:MED&resulttype=core&format=json

14 December 2019

author name string

Nicole A Kratochwil

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392818 AND SRC:MED&resulttype=core&format=json

14 December 2019

Walter Huber

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392818 AND SRC:MED&resulttype=core&format=json

14 December 2019

Francis Müller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392818 AND SRC:MED&resulttype=core&format=json

14 December 2019

Manfred Kansy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392818 AND SRC:MED&resulttype=core&format=json

14 December 2019

Paul R Gerber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392818 AND SRC:MED&resulttype=core&format=json

14 December 2019

language of work or name

English

0 references

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392818 AND SRC:MED&resulttype=core&format=json

14 December 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392818 AND SRC:MED&resulttype=core&format=json

14 December 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392818 AND SRC:MED&resulttype=core&format=json

14 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392818 AND SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

1355-1374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392818 AND SRC:MED&resulttype=core&format=json

The Role of the Therapeutic Regimen in Dosage Design. Part I

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

The location of drug binding sites in human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Fatty acid binding to human serum albumin: new insights from crystallographic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Crystal structure of human serum albumin at 2.5 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Atomic structure and chemistry of human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Effect of Plasma Protein Binding on in Vivo Activity and Brain Penetration of Glycine/NMDA Receptor Antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Three-Dimensional Quantitative Structure−Activity Relationships from Molecular Similarity Matrices and Genetic Neural Networks. 2. Applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Three-Dimensional Quantitative Structure−Activity Relationships from Molecular Similarity Matrices and Genetic Neural Networks. 1. Method and Validations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Charge distribution from a simple molecular orbital type calculation and non-bonding interaction terms in the force field MAB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Measurement and analysis of unbound drug concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Biosensor Analysis of the Interaction between Immobilized Human Serum Albumin and Drug Compounds for Prediction of Human Serum Albumin Binding Levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Determination of the free fraction and relative free fraction of drugs strongly bound to plasma proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

What is the True Clinical Significance of Plasma Protein Binding Displacement Interactions?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Plasma protein binding displacement interactions--why are they still regarded as clinically important?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Quantitative structure-pharmacokinetic relationships and drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Relationship between lipophilicity and binding to human serum albumin of arylpropionic acid non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Interaction mode of dicumarol and its derivatives with human serum albumin, alpha 1-acid glycoprotein and asialo alpha 1-acid glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Plasma Protein Binding of Gyrase Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Relationship between lipophilicity and binding affinity with human serum albumin for penicillin and cephem antibiotics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Lipophilicity in PK design: methyl, ethyl, futile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

The binding of benzopyranes to human serum albumin. A structure-affinity study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of coumarins to site I of human serum albumin. Effect of the fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Fluorescence energy transfer study of the relationship between the lone tryptophan residue and drug binding sites in human serum albumin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding sites of fluorescent probes on human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

A novel binding site for bile acids on human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of certain acidic drugs to human albumin: Theoretical and practical estimation of fundamental parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Characterization of site I on human serum albumin: concept about the structure of a drug binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Plasma and tissue protein binding of drugs in pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Aspirin binding and the effect of albumin on spontaneous and enzyme-catalysed hydrolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Thermodynamic characterization of drug binding to human serum albumin by isothermal titration microcalorimetry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Interaction of small ligands with human serum albumin IIIA subdomain. How to determine the affinity constant using an easy steady state fluorescent method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Azapropazone binding to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of nonsteroidal anti-inflammatory agents and their effect on binding of racemic warfarin and its enantiomers to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

A dynamic model for bilirubin binding to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Studies of the affinity of human serum albumin for binding of bilirubin at different temperatures and ionic strength

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Role of salt bridge(s) in the binding and photoconversion of bilirubin bound to high affinity site on human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Mutual interaction between bilirubin and cefazolin in binding to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Camptothecin-binding site in human serum albumin and protein transformations induced by drug binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Marked interspecies variations concerning the interactions of camptothecin with serum albumins: a frequency-domain fluorescence spectroscopic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Differential interactions of camptothecin lactone and carboxylate forms with human blood components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Drug-protein binding: recent advances in methodology: spectroscopic techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Study of interaction of carprofen and its enantiomers with human serum albumin--I. Mechanism of binding studied by dialysis and spectroscopic methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Study of interaction of carprofen and its enantiomers with human serum albumin--II. Stereoselective site-to-site displacement of carprofen by ibuprofen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Characterization of high affinity binding sites of non-steroidal anti-inflammatory drugs with respect to site-specific probes on human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of carprofen to human and bovine serum albumins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Structural specificity requirements in the binding of beta lactam antibiotics to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Cefazolin serum protein binding and its inhibition by bilirubin, fatty acids and other drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Structure-binding relationship and binding sites of cephalosporins in human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Ceftriaxone binding to human serum albumin. Indirect displacement by probenecid and diazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Microcalorimetric method to determine competitive binding action of a psychotropic drug (dipotassium chlorazepate) on L-tryptophan · human serum albumin complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

The binding of chlorothiazide to plasma proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Interaction of benzothiadiazides with human serum albumin studied by dialysis and spectroscopic methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

The existence of conformationally labile (preformed) drug binding sites in human serum albumin as evidenced by optical rotation measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Examination of phenothiazine-albumin interaction by ultraviolet difference spectrophotometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

The binding of chlorpromazine to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Competition for plasma protein binding sites between phenothiazine tranquillizers and iminodibenzyl antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

The binding of sulphonylureas to serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Cicletanine binding to human plasma proteins and erythrocytes, a particular HSA-drug interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Characterisation of domain fragments of recombinant human albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Relations between high-affinity binding sites of markers for binding regions on human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

High-affinity binding of warfarin, salicylate and diazepam to natural mutants of human serum albumin modified in the C-terminal end

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

The role of albumin conformation in the binding of diazepam to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Acetaldehyde adducts with serum proteins: effect on diazepam and phenytoin binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Direct and indirect determination of binding constants of drug-protein complexes with microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Characterization of the binding of benzodiazepines to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Diclofenac binding to albumin and lipoproteins in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Glycation of human serum albumin: inhibition by Diclofenac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Some quantitative investigations of the binding to and the displacement of bishydroxycoumarin from human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Interaction of bishydroxycoumarin with human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Multiple cobinding of two ligands to serum albumin: a stoichiometric description of binding equilibria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Characterisation of the binding of digitoxin and acetyldigitoxin to human serum albumin by high-performance affinity chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of digitoxin and some related cardenolides to human plasma proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Characterization of minor site probes for human serum albumin by high-performance affinity chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Stereoselective binding of etodolac to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Albumin binding sites for etodolac enantiomers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

The binding of aryl carboxylic acid derivatives to human serum albumin--a structure-activity study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Comparison of graphical and computerized methods for calculating binding parameters for two strongly bound drugs to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Multi-site binding of fenoprofen to human serum albumin studied by a combined technique of microdialysis with high performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Enhanced albumin protein separations and protein-drug binding constant measurements using anti-inflammatory drugs as run buffer additives in affinity capillary electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

The binding of flurbiprofen to plasma proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Mode of interaction of loop diuretics with human serum albumin and characterization of binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Effects of fatty acids on serum binding between furosemide and valproic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Study of binding of low-molecular-weight ligand to biological macromolecules by high-performance liquid chromatography. Evaluation of binding parameters for two drugs bound to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Influence of glycosylation on the drug binding of human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Influence of free fatty acid concentration on drug binding to plasma albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of nonsteroidal anti-inflammatory agents to proteins—I. Ibuprofen-serum albumin interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Pharmacokinetics of ibuprofen in man--III: Plasma protein binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of non-steroidal anti-inflammatory drugs to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

The effect of octanoic acid on the binding of the enantiomers of ibuprofen and naproxen to human serum albumin: a chromatographic implication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

A quantitative circular dichroic investigation of the binding of the enantiomers of ibuprofen and naproxen to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Stereoselectivity and enantiomer-enantiomer interactions in the binding of ibuprofen to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Stereoselective, competitive, and nonlinear plasma protein binding of ibuprofen enantiomers as determined in vivo in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Characterization of the protein binding of chiral drugs by high-performance affinity chromatography interactions of R- and S-ibuprofen with human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Molecular basis of indomethacin-human serum albumin interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Protein binding of indomethacin: binding of indomethacin to human plasma albumin and its displacement from binding by ibuprofen, phenylbutazone and salicylate, in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of drugs to human serum albumin--XV. Characterization and identification of the binding sites of indomethacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Some novel observations of a drug (indoprofen)--albumin interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Competitive binding of bilirubin, sulfobromophthalein, indocyanine green and other organic anions to human and bovine serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Stereoselective protein binding of ketoprofen: effect of albumin concentration and of the biological system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

INTERACTION OF HUMAN SERUM PROTEINS WITH LOCAL ANESTHETIC AGENTS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Structural requirements for binding of nonsteroidal anti-inflammatory drugs to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Characterization of discrete classes of binding sites of human serum albumin by application of thermodynamic principles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Equilibrium dialysis and circular dichroic analysis of the novobiocin-human serum albumin complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

A general, wide-rage spectrofluorometric method for measuring the site-specific affinities of drugs toward human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Effect of albumin conformation on binding of phenylbutazone and oxyphenbutazone to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

The measurement of binding constants using circular dichroism. Binding of phenylbutazone and oxyphenbutazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

The interaction of enflurane, halothane and the halothane metabolite trifluoroacetic acid with the binding of acidic drugs to human serum albumin. An in vitro study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of pirprofen to human serum albumin studied by dialysis and spectroscopy techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Interaction of pirprofen enantiomers with human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Steroid binding to human serum albumin and fragments thereof. Role of protein conformation and fatty acid content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Effect of temperature on the binding of salicylate by human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Protein binding methodology: comparison of equilibrium dialysis and frontal analysis chromatography in the study of salicylate binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Effect of pH and small inorganic ions on binding of sulfadimethoxine and sulfaphenazole to human serum albumin measured by circular dichroism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of sulfobromophthalein (BSP) sodium by plasma albumin. Its role in hepatic BSP extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Interaction of sulindac and metabolite with human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of suprofen to human serum albumin. Role of the suprofen carboxyl group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Hormone binding to natural mutants of human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Effects of free fatty acids on the binding of bovine and human serum albumin with steroid hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Mutagenesis studies of thyroxine binding to human serum albumin define an important structural characteristic of subdomain 2A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Equilibrium dialysis studies of the binding of thyroxine by human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

MOLECULAR STRUCTURE OF THYROXINE IN RELATION TO ITS BINDING BY HUMAN SERUM ALBUMIN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

THYROXINE-PROTEIN INTERACTIONS. II. THE BINDING OF THYROXINE AND ITS ANALOGUES TO HUMAN SERUM ALBUMIN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Thyroxine-protein interactions. VI. Structural requirements for binding of benzene derivatives to thyroxine-binding sites on human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Localization of tolbutamide binding sites on human serum albumin using titration calorimetry and heteronuclear 2-D NMR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of Sulfonylureas to Serum Proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of four sulphonamides to human albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding position of tolbutamide to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Effects of nonenzymatic glycosylation and fatty acids on tryptophan binding to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Development of tryptophan-modified human serum albumin columns for site-specific studies of drug-protein interactions by high-performance affinity chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Characterization of the binding and chiral separation of D- and L-tryptophan on a high-performance immobilized human serum albumin column

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

A highly reactive tyrosine residue as part of the indole and benzodiazepine binding site of human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Study of interaction between drug enantiomers and serum albumin by capillary electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Studies on the Coumarin Anticoagulant Drugs: Interaction of Human Plasma Albumin and Warfarin Sodium*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Effect of temperature on binding of warfarin by human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Influence of heavy metals on the in vitro interaction between human serum albumin and warfarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Cooperativity of warfarin binding with human serum albumin induced by free fatty acid anion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

New procedure for analysing drug binding data, exemplified by warfarin binding to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

High-affinity binding of two molecules of warfarin and phenprocoumon to human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Spectroscopic techniques in the study of protein binding. A fluorescence technique for the evaluation of the albumin binding and displacement of warfarin and warfarin-alcohol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

Binding of Digitoxin to Human Serum Proteins: Influence of pH on the Binding of Digitoxin to Human Albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

inferred from DOI database lookup

7 January 2021

based on heuristic

The Determination of Naproxen by Spectrofluorometry and its Binding to Serum Proteins

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(02)01074-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(02)01074-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392818 AND SRC:MED&resulttype=core&format=json

14 December 2019

1 reference